Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > A Covid Vaccine Would Be Helpful

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Oct 20, 2022 12:31pm

124 Views

Post# 35036649

RE:A Covid Vaccine Would Be Helpful

2b7f6fab wrote:
https://www.unz.com/runz/covid-and-the-death-of-billions/

US researchers have developed a new lethal Covid strain in a laboratory – echoing the type of experiments many fear started the pandemic.

The mutant variant — which is a hybrid of Omicron and the original Wuhan virus — killed 80 percent of mice infected with it at Boston University.

When a similar group of rodents were exposed to the standard Omicron strain, however, they all survived and only experienced ‘mild’ symptoms.

The scientists also infected human cells with the hybrid variant and found it was five times more infectious than Omicron.